Stabilization of RelB requires multidomain interactions with p100/p52

被引:61
作者
Fusco, Amanda J. [1 ]
Savinova, Olga V. [1 ]
Talwar, Rashmi [1 ]
Kearns, Jeffrey D. [1 ,2 ]
Hoffmann, Alexander [1 ,2 ]
Ghosh, Gourisankar [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Signaling Syst Lab, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M707898200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The NF-kappa B family member RelB has many properties not shared by other family members such as restricted subunit association and lack of regulation by the classical I kappa B proteins. We show that the protein level of RelB is significantly reduced in the absence of p100 and reduced even more when both p100 and p105 are absent. RelB stabilizes itself by directly interacting with p100, p105, and their processed products. However, RelB forms complexes with its partners using different interaction modes. Although the C-terminal ankyrin repeat domain of p105 is not involved in the RelB-p105 complex formation, all domains and flexible regions of each protein are engaged in the RelB-p100 complex. In several respects the RelB-p52 and RelB-p100 complexes are unique in the NF-kappa B family. The N-terminal domain of p100/p52 interacts with RelB but not RelA. The transcriptional activation domain of RelB, but not RelA, directly interacts with the processing region of p100. These unique protein-protein contacts explain why RelB prefers p52 as its dimeric partner for transcriptional activity and is retained in the cytoplasm as an inhibited complex by p100. This association-mediated stabilization of RelB implies a possible role for RelB in the processing of p100 into p52.
引用
收藏
页码:12324 / 12332
页数:9
相关论文
共 33 条
[1]
20S proteasomal degradation of ornithine decarboxylase is regulated by NQ01 [J].
Asher, G ;
Bercovich, Z ;
Tsvetkov, P ;
Shaul, Y ;
Kahana, C .
MOLECULAR CELL, 2005, 17 (05) :645-655
[2]
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQ01 [J].
Asher, G ;
Lotem, J ;
Sachs, L ;
Kahana, C ;
Shaul, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13125-13130
[3]
The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[4]
A fourth IκB protein within the NF-κB signaling module [J].
Basak, Soumen ;
Kim, Hana ;
Kearns, Jeffrey D. ;
Tergaonkar, Vinay ;
O'Dea, Ellen ;
Werner, Shannon L. ;
Benedict, Chris A. ;
Ware, Carl F. ;
Ghosh, Gourisankar ;
Verma, Inder M. ;
Hoffmann, Alexander .
CELL, 2007, 128 (02) :369-381
[5]
Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers [J].
Bonizzi, G ;
Bebien, M ;
Otero, DC ;
Johnson-Vroom, KE ;
Cao, YX ;
Vu, D ;
Jegga, AG ;
Aronow, BJ ;
Ghosh, G ;
Rickert, RC ;
Karin, M .
EMBO JOURNAL, 2004, 23 (21) :4202-4210
[6]
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells [J].
Claudio, E ;
Brown, K ;
Park, S ;
Wang, HS ;
Siebenlist, U .
NATURE IMMUNOLOGY, 2002, 3 (10) :958-965
[7]
CD40 regulates the processing of NF-κB2 p100 to p52 [J].
Coope, HJ ;
Atkinson, PGP ;
Huhse, B ;
Belich, M ;
Janzen, J ;
Holman, MJ ;
Klaus, GGB ;
Johnston, LH ;
Ley, SC .
EMBO JOURNAL, 2002, 21 (20) :5375-5385
[8]
The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways [J].
Dejardin, E ;
Droin, NM ;
Delhase, M ;
Haas, E ;
Cao, YX ;
Makris, C ;
Li, ZW ;
Karin, M ;
Ware, CF ;
Green, DR .
IMMUNITY, 2002, 17 (04) :525-535
[9]
Genetic evidence for the essential role of β-transducin repeat-containing protein in the inducible processing of NF-κB2/p100 [J].
Fong, A ;
Sun, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22111-22114
[10]
Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture [J].
Franzoso, G ;
Carlson, L ;
Poljak, L ;
Shores, EW ;
Epstein, S ;
Leonardi, A ;
Grinberg, A ;
Tran, T ;
Scharton-Kersten, T ;
Anver, M ;
Love, P ;
Brown, K ;
Siebenlist, U .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :147-159